Based on our results, we suggest that enhancement of Trak1-mediated mitochondrial fusion could represent a novel therapeutic strategy to combat mitochondrial fragmentation in a number of neurodegenerative diseases. This evidence concerns the gene TRAK1 and neurodegenerative disease.